BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30814080)

  • 1. Influence of Docosahexaenoic Acid on Proliferation and Apoptosis in Human HepG2 Cell Line.
    Chen YJ; Jiang HT; Wang TF
    Ann Clin Lab Sci; 2019 Jan; 49(1):72-78. PubMed ID: 30814080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of fatty acid synthase (FASN) affects the proliferation and apoptosis of HepG2 hepatoma carcinoma cells via the β-catenin/C-myc signaling pathway.
    Zhang W; Huang J; Tang Y; Yang Y; Hu H
    Ann Hepatol; 2020; 19(4):411-416. PubMed ID: 32536483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling.
    Shi QQ; Zuo GW; Feng ZQ; Zhao LC; Luo L; You ZM; Li DY; Xia J; Li J; Chen DL
    Asian Pac J Cancer Prev; 2014; 15(18):7849-55. PubMed ID: 25292076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydroartemisinin induces endoplasmic reticulum stress-mediated apoptosis in HepG2 human hepatoma cells.
    Gao X; Luo Z; Xiang T; Wang K; Li J; Wang P
    Tumori; 2011; 97(6):771-80. PubMed ID: 22322845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway.
    Sun H; Gao Y; Lu K; Zhao G; Li X; Li Z; Chang H
    World J Surg Oncol; 2015 Oct; 13():307. PubMed ID: 26499380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids inhibit hepatocellular carcinoma cell growth through blocking beta-catenin and cyclooxygenase-2.
    Lim K; Han C; Dai Y; Shen M; Wu T
    Mol Cancer Ther; 2009 Nov; 8(11):3046-55. PubMed ID: 19887546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
    Zou WJ; Huang Z; Jiang TP; Shen YP; Zhao AS; Zhou S; Zhang S
    Med Sci Monit; 2017 Dec; 23():6107-6113. PubMed ID: 29276937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic acid promotes cell cycle arrest and decreases proliferation through WNT/β-catenin modulation in colorectal cancer cells exposed to γ-radiation.
    Murad LB; da Silva Nogueira P; de Araújo WM; Sousa-Squiavinato ACM; Rocha MR; de Souza WF; de-Freitas-Junior J; Barcellos-de-Souza P; Bastos LG; Morgado-Díaz JA
    Biofactors; 2019 Jan; 45(1):24-34. PubMed ID: 30521071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guggulsterone induces apoptosis of human hepatocellular carcinoma cells through intrinsic mitochondrial pathway.
    Shi JJ; Jia XL; Li M; Yang N; Li YP; Zhang X; Gao N; Dang SS
    World J Gastroenterol; 2015 Dec; 21(47):13277-87. PubMed ID: 26715810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
    Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
    Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-3 polyunsaturated fatty acid inhibits the malignant progression of hepatocarcinoma by inhibiting the Wnt/β-catenin pathway.
    Chang FZ; Wang Q; Zhang Q; Chang LL; Li W
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4500-4508. PubMed ID: 30058686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suppression of c-myc expression by interference RNA in HepG2 hepatocellular carcinoma cells].
    Xu Y; Wang YH; Gao JD; Ye J; Zhu HX; Xu NZ; Wang XY; Sun ZT
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):458-60. PubMed ID: 15555332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle effects of docosahexaenoic acid on human metastatic hepatocellular carcinoma proliferation.
    Lee CY; Sit WH; Fan ST; Man K; Jor IW; Wong LL; Wan ML; Tan-Un KC; Wan JM
    Int J Oncol; 2010 Apr; 36(4):991-8. PubMed ID: 20198345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichlorodiphenyltrichloroethane exposure induces the growth of hepatocellular carcinoma via Wnt/β-catenin pathway.
    Jin XT; Song L; Zhao JY; Li ZY; Zhao MR; Liu WP
    Toxicol Lett; 2014 Feb; 225(1):158-66. PubMed ID: 24355586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research on anti-hepatocellular carcinoma activity and mechanism of Polygala fallax Hemsl.
    Yao Z; Li Y; Wang Z; Lan Y; Zeng T; Gong H; Zhu K; Tang H; Gu S
    J Ethnopharmacol; 2020 Oct; 260():113062. PubMed ID: 32512042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
    Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
    Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the role of Wnt/beta-catenin signaling transduction pathway in hepatocellular carcinoma cell line HepG2 and L02 cell line].
    Wang QM; Jia LQ; Zhou HY; Li YS
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Oct; 23(10):926-8. PubMed ID: 17908501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pivotal Role of Long Noncoding RNA RAB5IF in the Proliferation of Hepatocellular Carcinoma Via LGR5 Mediated β-Catenin and c-Myc Signaling.
    Koo JI; Lee HJ; Jung JH; Im E; Kim JH; Shin N; Sim DY; Hwang J; Kim SH
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31717443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both glypican-3/Wnt/β-catenin signaling pathway and autophagy contributed to the inhibitory effect of curcumin on hepatocellular carcinoma.
    Hu P; Ke C; Guo X; Ren P; Tong Y; Luo S; He Y; Wei Z; Cheng B; Li R; Luo J; Meng Z
    Dig Liver Dis; 2019 Jan; 51(1):120-126. PubMed ID: 30001951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.